Eosinophilic peritonitis in a patient with continuous ambulatory peritoneal dialysis (CAPD). 2004

Se Yong Oh, and Hyang Kim, and Jeung Mook Kang, and Sung Ho Lim, and Hyun Duk Park, and Soo Suk Jung, and Kyu Beck Lee
Department of Internal Medicine, Sungkyunkwan University School of Medicine, Kangbuk Samsung Hospital, Seoul, Korea.

Eosinophilic peritonitis is defined as when there are more than 100 eosinophils present per milliliter of peritoneal effluent, of which eosinophils constitute more than 10% of its total WBC count. Most cases occur within the first 4 weeks of peritoneal catheter insertion and they usually have a benign and self-limited course. We report a patient of eosinophilic peritonitis that was successfully resolved without special treatment. An 84-year-old man with end stage renal disease secondary to diabetic nephropathy was admitted for dyspnea and poor oral intake. Allergic history was negative. and physical examination was unremarkable. Complete blood count showed a hemoglobin level of 11.1 g/dL, WBC count was 24,500/mm3 (neutrophil, 93%; lymphocyte, 5%; monocyte, 2%), platelet count was 216,000/mm3, serum BUN was 143 mg/dL, Cr was 5.7 mg/dL and albumin was 3.5 g/dL. Creatinine clearance was 5.4 mL/min. Three weeks after peritoneal catheter insertion, he was started on peritoneal dialysis with a 6-hour exchange of 2L 1.5% peritoneal dialysate. After nine days, he developed turbid peritoneal effluents with fever (38.4 degrees C), abdominal pain and tenderness. Dialysate WBC count was 180/mm3 (neutrophil, 20%; lymphocyte, 4%; eosinophil, 76% [eosinophil count: 136/mm3]). Cultures of peritoneal fluid showed no growth of aerobic or anaerobic bacteria, or of fungus. Continuous ambulatory peritoneal dialysis (CAPD) was commenced, and he was started on intraperitoneal ceftazidime (1.0 g/day) and cefazolin (1.0 g/day). After two weeksr, the dialysate had cleared up and clinical symptoms were improved. Dialysate WBC count decreased to 8/mm3 and eosinophils were not detected in peritoneal fluid. There was no recurrence of eosinophilic peritonitis on follow-up evaluation, but he died of sepsis and pneumonia fifteen weeks after admission.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D010538 Peritonitis INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs. Primary Peritonitis,Secondary Peritonitis,Peritonitis, Primary,Peritonitis, Secondary
D002437 Cefazolin A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine. Cephazolin,Ancef,Cefamedin,Cefamezine,Cefazolin Sodium,Cephamezine,Cephazolin Sodium,Gramaxin,Kefzol,Sodium Cephazolin,Totacef,Cephazolin, Sodium,Sodium, Cefazolin,Sodium, Cephazolin
D002442 Ceftazidime Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients. Ceftazidime Anhydrous,Ceftazidime Pentahydrate,Fortaz,Fortum,GR-20263,LY-139381,Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))-,Tazidime,GR 20263,GR20263,LY 139381,LY139381
D003928 Diabetic Nephropathies KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. Diabetic Glomerulosclerosis,Glomerulosclerosis, Diabetic,Diabetic Kidney Disease,Diabetic Nephropathy,Intracapillary Glomerulosclerosis,Kimmelstiel-Wilson Disease,Kimmelstiel-Wilson Syndrome,Nodular Glomerulosclerosis,Diabetic Kidney Diseases,Glomerulosclerosis, Nodular,Kidney Disease, Diabetic,Kidney Diseases, Diabetic,Kimmelstiel Wilson Disease,Kimmelstiel Wilson Syndrome,Nephropathies, Diabetic,Nephropathy, Diabetic,Syndrome, Kimmelstiel-Wilson
D004802 Eosinophilia Abnormal increase of EOSINOPHILS in the blood, tissues or organs. Eosinophilia, Tropical,Hypereosinophilia,Tropical Eosinophilia,Hypereosinophilias,Tropical Eosinophilias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

Se Yong Oh, and Hyang Kim, and Jeung Mook Kang, and Sung Ho Lim, and Hyun Duk Park, and Soo Suk Jung, and Kyu Beck Lee
June 1981, Clinical nephrology,
Se Yong Oh, and Hyang Kim, and Jeung Mook Kang, and Sung Ho Lim, and Hyun Duk Park, and Soo Suk Jung, and Kyu Beck Lee
August 1985, Ugeskrift for laeger,
Se Yong Oh, and Hyang Kim, and Jeung Mook Kang, and Sung Ho Lim, and Hyun Duk Park, and Soo Suk Jung, and Kyu Beck Lee
October 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Se Yong Oh, and Hyang Kim, and Jeung Mook Kang, and Sung Ho Lim, and Hyun Duk Park, and Soo Suk Jung, and Kyu Beck Lee
January 1989, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
Se Yong Oh, and Hyang Kim, and Jeung Mook Kang, and Sung Ho Lim, and Hyun Duk Park, and Soo Suk Jung, and Kyu Beck Lee
January 1990, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
Se Yong Oh, and Hyang Kim, and Jeung Mook Kang, and Sung Ho Lim, and Hyun Duk Park, and Soo Suk Jung, and Kyu Beck Lee
January 1991, Enfermedades infecciosas y microbiologia clinica,
Se Yong Oh, and Hyang Kim, and Jeung Mook Kang, and Sung Ho Lim, and Hyun Duk Park, and Soo Suk Jung, and Kyu Beck Lee
January 1991, International archives of allergy and applied immunology,
Se Yong Oh, and Hyang Kim, and Jeung Mook Kang, and Sung Ho Lim, and Hyun Duk Park, and Soo Suk Jung, and Kyu Beck Lee
March 1990, Postgraduate medical journal,
Se Yong Oh, and Hyang Kim, and Jeung Mook Kang, and Sung Ho Lim, and Hyun Duk Park, and Soo Suk Jung, and Kyu Beck Lee
January 1990, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
Se Yong Oh, and Hyang Kim, and Jeung Mook Kang, and Sung Ho Lim, and Hyun Duk Park, and Soo Suk Jung, and Kyu Beck Lee
July 1991, Clinical nephrology,
Copied contents to your clipboard!